10th Mar 2010 15:11
AGI Therapeutics PLC
Notification of Results
AGI Therapeutics plc ("AGI" or the "Company") (AIM, IEX: AGI), a speciality pharmaceutical company, will be announcing its preliminary results for the year ended 31 December 2009 on Wednesday, 14th April 2009.
Contact Information:
|
AGI Therapeutics plc. |
Tel: +353 1 449 3254 |
|
David Kelly, Chief Financial Officer |
|
|
|
|
|
|
|
|
Davy John Frain |
Tel: +353 (1) 614 6363
|
|
|
|
Notes to Editors:
About AGI Therapeutics plc
AGI is a specialty pharmaceutical company which is focused on the development and commercialisation of differentiated specialty drug products to treat unmet medical needs, including conditions which qualify for Orphan drug status.
The Company aims to bring its products to the market either directly or through out-licensing or other partnering arrangements.
AGI's common shares are listed on the Alternative Investment Market of the London Stock Exchange (AIM) and on the Irish Enterprise Exchange of the Irish Stock Market (IEX) as AGI.
For further information please see www.agitherapeutics.com
Related Shares:
Potentially Ai